Histone Modifications in Therapy
Series: Translational Epigenetics; 20;
- Publisher's listprice EUR 162.00
-
63 277 Ft (60 264 Ft + 5% VAT)
The price is estimated because at the time of ordering we do not know what conversion rates will apply to HUF / product currency when the book arrives. In case HUF is weaker, the price increases slightly, in case HUF is stronger, the price goes lower slightly.
- Discount 20% (cc. 12 655 Ft off)
- Discounted price 50 622 Ft (48 211 Ft + 5% VAT)
- Discount is valid until: 30 June 2026
Subcribe now and take benefit of a favourable price.
Subscribe
63 277 Ft
Availability
printed on demand
Why don't you give exact delivery time?
Delivery time is estimated on our previous experiences. We give estimations only, because we order from outside Hungary, and the delivery time mainly depends on how quickly the publisher supplies the book. Faster or slower deliveries both happen, but we do our best to supply as quickly as possible.
Product details:
- Publisher Elsevier Science
- Date of Publication 21 August 2020
- ISBN 9780128164228
- Binding Paperback
- No. of pages490 pages
- Size 234x190 mm
- Weight 1020 g
- Language English 31
Categories
Long description:
Histone Modifications in Therapy provides an in-depth analysis of the role of histone mechanisms in major diseases and the promise of targeting histone modifications for disease prevention and treatment. Here, researchers, clinicians and students will discover a thorough, evidence-based discussion of the biology of histones, the diseases engaged by aberrant histone modifications, and pathways with therapeutic potential. Expert chapter addresses the role of histone modifications across a variety of disorders, including cancer, neuropsychiatric, neurodegenerative, cardiac, metabolic, infectious, bacterial, autoimmune and inflammatory disorders, among others. In relation to these disease types, histone modifications are discussed, both as mechanisms of prevention and possible treatment.
A concluding chapter brings together future perspectives for targeting histone modifications in therapy and next steps in research.
MoreTable of Contents:
1. Histone modifications in diseases
Section I Targeting histone modifications for cancer treatment
2. HDAC inhibitors in cancer therapy
3. HAT inhibitors in cancer therapy
4. Targeting DOT1L for mixed-lineage rearranged leukemia
5. BET mechanisms in cancer
6. Histone demethylase inhibitors and their potential in cancer treatment
7. Targeting chromatin remodelers in urological tumors
Section II Targeting histone modifications for infectious disease
8. The therapeutic potential of epigenetic manipulation during infectious diseases
9. Targeting histone deacetylases for bacterial infections
10. Targeting histone epigenetics to control viral infections
Section III Targeting histone modifications for treating other pathologies
11. Targeting histone modifications in psychotic disorders
12. Epigenetic treatment of neurodegenerative diseases
13. Histone modification as a potential preventative and therapeutic approach for cardiovascular disease
14. The potentiality of histone deacetylase inhibitors for diabetes and obesity
15. Targeting histone modifications in cancer immunotherapy
16. Epigenetic drug development for autoimmune and inflammatory diseases
17. Future perspectives for targeting histone modifications in therapy
